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Abstract. Background/Aim: To investigate the
clinicopathological characteristics of high-grade squamous
intraepithelial lesions (HSILs) and squamous cell
carcinomas (SCCs) involving endocervical polyps (ECPs).
Patients and Methods: We collected the endocervical
polypectomy cases and performed pathological examination
and cytohistological correlation. Results: During a period of
12 years, 21 (1.1%) HSILs and two (0.1%) SCCs involving
ECPs were identified in 1,905 cases. Twelve (63.1%) of the
19 cases were cytohistologically concordant. In five HSILs
and one SCC with polypectomy margin involvement, residual
HSIL was identified in conization or hysterectomy specimens.
Furthermore, in two HSIL patients and one SCC patient with
negative polypectomy margins, residual HSILs were found in
the conization specimens. Conclusion: The prevalence of
HSIL and SCC involving ECP in our cohort was similar to
the rates found in previous studies. The presence of residual
HSIL in nonpolypoid cervical tissue regardless of the
polypectomy margin involvement suggests that conization or
hysterectomy is needed for diagnostic or treatment purposes.
Endocervical polyps (ECPs) are the most common benign
neoplasms of the uterine cervix that characteristically arise in
the endocervical canal (1). They can occur over a wide age
range, but about 90% of patients are aged >40 years (2). The
reported prevalence of ECP is 1.5-10%, and its pathogenesis
remains unknown. Focal reactive epithelial and stromal
hyperplasia associated with repeated episodes of inflammation,
an abnormal local response to increased estrogen levels, or
local congestion of cervical stromal blood vessels might be
involved in the development of ECP (1, 3). Approximately
60% of ECP patients is asymptomatic and discovered
incidentally during routine gynecologic examinations, whereas
symptomatic ECPs manifest as menorrhagia, metrorrhagia,
postcoital bleeding, postmenopausal bleeding, vaginal
discharge, or leukorrhea (2, 4).
Even though the reported prevalence of malignancies
arising from ECP is 0.1-0.5%, a thorough literature review
revealed no information about malignancies involving ECP
in Asian women (2, 3). We recently experienced several
patients with high-grade squamous intraepithelial lesions
(HSIL) and squamous cell carcinoma (SCC) involving ECP,
which initiated a comprehensive review of our archival
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records. In this study, we aimed to determine the prevalence
of HSILs and SCCs involving ECP and to investigate their
clinical characteristics and pathological features, as well as
the relationship between cytology and human papillomavirus
(HPV) results.
Patients and Methods
Patient selection. This retrospective study (4-2016-0549) was
reviewed and approved by the Institutional Review Board at
Severance Hospital (Republic of Korea). Cases were collected by
searching the pathology database for ECP between 1996 and 2018.
The search included all reports with the terms “cervical”,
“endocervical”, “polypoid”, and “polyp”. We identified 1,976
patients with ECP. Multiple polyps in an individual single patient
discovered less than six months apart were taken as being the same
polyp. When data from an individual patient remained unchanged
for six months, only the most recent data were collected.
Consequently, 71 cases were excluded. Among 1,905 cases of ECP,
we extracted cases with HSIL or SCC involving ECP using the
histological criteria recommended by the World Health Organization
(WHO) Classification of Tumours of Female Reproductive Organs
(5) and the Lower Anogenital Squamous Terminology (LAST)
Standardization Project (6). The clinical features were determined
from reviews of the electronic medical records, or by
communicating with referring gynecologists. Images were reviewed
where available. The primary lesions of all 1,905 patients were
histologically assessed by two board-certified pathologists
specialized in gynecological oncology. They examined all available
hematoxylin and eosin-stained slides, concluded pathological
diagnoses, and selected representative slides for immunostaining
and HPV genotyping.
Immunohistochemical staining and interpretation. Sections (4-μm
thick) cut from formalin-fixed, paraffin-embedded tissue blocks
were placed onto Superfrost Plus glass slides (Thermo Fisher
Scientific, Waltham, MA, USA). Thereafter, the sections were
deparaffinized in xylene, rehydrated through a series of graded
alcohols and immunohistochemically stained using an automated
Ventana Benchmark XT (Ventana Medical Systems Inc.) as
described by the manufacturer (7-13). Antigen was retrieved using
CC1 Cell Conditioning Solution (Ventana Medical Systems Inc.).
The sections were incubated with primary antibody for p16 using
prediluted clone E6H4 (Ventana Medical Systems Inc.). After
chromogenic visualization using an ultraView Universal DAB
Detection Kit (Ventana Medical Systems Inc.), the slices were
counterstained with hematoxylin, dehydrated in graded alcohols and
xylene, and then embedded in mounting solution. Appropriate
positive and negative controls were concurrently stained to validate
the staining method. Cervical invasive squamous cell carcinoma and
endometrial serous carcinoma tissue samples obtained by radical
hysterectomy were used as positive controls. According to the
recommendation of the LAST Standardization Project (6), the
immunostaining profile of p16 was interpreted as block positive
when p16 expression was horizontally continuous and strong, with
nuclear or nuclear plus cytoplasmic staining. All other p16
immunostaining profiles, described as focal nuclear, wispy, blob-
like, puddled, or scattered cytoplasmic staining were interpreted as
patchy positive (9, 14-19).
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Table I. Clinical characteristics of high-grade squamous intraepithelial lesion (HSIL) and squamous cell carcinoma (SCC) involving endocervical
polyp.
Characteristic Polypectomy diagnosis Total
HSIL SCC
Number of cases 21 2 23
Age (years) Mean (range) 49.9 (30-84) 58 (53-63) 50.6 (30-84)
Human papillomavirus status High-risk detected 15 1 16
Not detected 2 0 2
Not applicable 4 1 5
Cytology diagnosis SCC 0 1 1
HSIL 5 0 5
Atypical squamous cells, cannot exclude HSIL 6 0 6
Low-grade squamous intraepithelial lesion 1 0 1
Atypical squamous cells of undetermined significance 4 1 5
Negative for intraepithelial lesion or malignancy 1 0 1
Not applicable 4 0 4
Surgical treatment Conization only 6 1 7
after polypectomy Hysterectomy only 4 1 5
Conization and hysterectomy 3 0 3
None 8 0 8
Follow-up period Mean (range) 44.3 (7-173) 16 (11-21) 41.4 (7-173)
Current status No evidence of disease 17 2 19
Not applicable 4 0 4
HPV genotyping assay. We used a commercially available
polymerase chain reaction (PCR)-based microarray with a HPV 9G
DNA chip (BMT HPV 9G DNA Chip; Biometrix Technology) (20-
22). The 9G test detects 14 high-risk (16, 18, 31, 33, 35, 39, 45, 51,
52, 56, 58, 59, 66, and 68) and five low-risk (6, 11, 34, 40, and 42)
HPV types as described by the manufacturer. Briefly, the PCR
mixture contained 10 μL of extracted target DNA, 10 μl of BMT
Primer set (Biometrix Technology), and PCR premix (Biometrix
Technology) contained dNTP and Taq DNA polymerase in
amplification buffer. Fragments of DNA were amplified using the
following cycling program: pre-denaturation at 94˚C for 5 min, 40
denaturation cycles at 94˚C for 30 s, 40 annealing cycles at 45˚C
for 30 s, 40 elongation cycles at 72˚C for 30 s, and final elongation
at 72˚C for 5 min. The PCR products were resolved by
electrophoresis in 2% agarose gels to confirm amplification. Each
hybridization chamber of the 9G was covered with a mixture of the
hybridization solution (35 μl) and PCR products (15 μl) and
incubated at 23˚C-26˚C for 30 min. The array was washed, then
images were acquired using a fluorescent ScanArray GX Microarray
scanner (PerkinElmer Life and Analytical Sciences Inc., Waltham,
MA, USA).
Results
Prevalence of HSIL and SCC involving ECP. During a study
period of 12 years, we identified 1,905 patients with ECP,
and most of the them were diagnosed with ECP without
additional descriptors. According to the histological criteria
for HSIL and SCC (5, 6), 21 and two patients each had HSIL
and SCC involving ECP. The prevalence of HSIL and SCC
involving ECP was 1.1% (21/1,905) and 0.1% (2/1,905),
respectively.
Clinical characteristics. Table I summarizes the
clinicopathological characteristics of the patients with HSIL
and SCC involving ECP. The two patients with SCC were
aged 53 and 63 (mean: 58) years and were postmenopausal.
The mean age of the 21 patients with HSIL was 49.9
(range=30-84) years and eight (38.1%) of these patients were
aged <45 years and premenopausal.
All except one patient underwent polypectomy under
hysteroscopic or colposcopic guidance, which revealed ECP
with various gross morphologies (Figure 1). The remaining
one patient underwent hysterectomy without polypectomy.
Nine (42.8%) HSIL patients were treated by cervical
conization after polypectomy, and three of those also
underwent total hysterectomy following conization. Four
(19.0%) HSIL patients underwent only hysterectomy. One of
the two patients with SCC was treated by radical
hysterectomy with bilateral external iliac lymph node
sampling, whereas the other patient underwent conization
with no further treatment after. None of the patients received
postoperative adjuvant chemotherapy or radiation therapy.
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Figure 1. Colposcopy features of endocervical polyps. (A and B) Case 10. (A) Head of pedunculated polyp projects beyond external os. (B) Long
stalk is apparently attached to endocervix. (C and D) Case 7. (C) Polyp protrudes from external os. (D) Small, deep red polyp resembles early
granulation tissue formation. (E and F) Case 11. (E) Cylindrical polypoid mass protrudes from endocervical canal and widens external os. (F)
Polyp surface has irregular-shaped superficial erosions and patchy hemorrhagic spots. (G and H) Case 13. (G) Small polyp has similar shape to
that in case 7. (H) Close-up view reveals gray-to-pink, slightly nodular appearance at surface.
Recurrent disease and metastasis did not arise in the two
patients with SCC during postoperative follow-up for 11 and
21 months, respectively. The patients with HSIL were
followed up for a mean of 44.3 months (range=7-173
months). All 17 (81.0%) patients with HSIL who had
complete follow-up information have remained alive without
evidence of recurrent disease.
HPV status. Information about HPV genotypes was available
for 18 (78.3%) patients: 17 patients with HSIL and one
patient with SCC. High-risk HPV was detected in 15 patients
with HSIL and in one with SCC (type 16). The most
prevalent genotype in the patients with HSIL was type 16
(7/15; 46.7%), followed by types 31 (2/15; 13.3%) and 52
(2/15; 13.3%). Types 18, 33, 39, and 68 were also detected.
High-risk HPV was not detected in the remaining two
patients with HSIL.
Cytohistological correlation. Cervicovaginal cytology results
were available for 19 (82.6%) patients. The findings for two
SCC patients were SCC and atypical squamous cells of
undetermined significance (ASC-US), respectively.
Seventeen patients with HSIL were diagnosed with atypical
squamous cells, cannot exclude HSIL (ASC-H; 6/17; 35.3%),
HSIL (5/17; 29.4%), ASC-US (4/17; 23.5%), low-grade
squamous intraepithelial lesion (LSIL; 1/17; 5.9%), and
negative for intraepithelial lesion or malignancy (NILM;
1/17; 5.9%). Taken together, ASC-H, HSIL, or SCC was
diagnosed in 12 (63.1%) of the 19 patients with cytological
results.
Pathological characteristics. Table II summarizes
pathological characteristics. The mean size of ECP was 13.9
mm (range=2-40 mm). The mean size of two ECP with SCC
was 15.5 (15-16) mm. Three and 18 patients with HSIL were
classified as cervical intraepithelial neoplasia (CIN) 2 and
CIN 3, respectively. The mean sizes of the largest ECP
classified as CIN 2 and CIN 3 were 5 and 15.2 mm,
respectively. Endocervical glandular extension by HSIL was
identified in 19 (90.5%) patients with HSIL and two
(100.0%) with SCC. Bizarre nuclear atypia, including
marked nuclear enlargement (4-5-fold larger than basal cell
nuclei) and severe pleomorphism, were found in six (28.6%)
patients with HSIL and one (50.0%) with SCC. Mitotic
activity was increased in all patients examined. Atypical
mitotic figures, including tripolar, tetrapolar, and asymmetric
mitoses, were detected in five (23.8%) and two (100.0%)
patients with HSIL and SCC, respectively. The greatest size
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Table II. Pathological characteristics of high-grade squamous intraepithelial lesion (HSIL) and squamous cell carcinoma (SCC) involving
endocervical polyp (ECP).
Characteristic Polypectomy diagnosis Total
HSIL SCC
Greatest size of ECP Mean (range) 13.7 (2-40) 15.5 (15-16) 13.9 (2-40)
<15 mm 13 0 13
≥15 mm 8 2 10
Greatest size of SCC <3 mm Not applicable 2 (<1 mm) 2
<5 mm Not applicable 0 0
≥5 mm Not applicable 0 0
Glandular extension Present 19 2 21
Absent 2 0 2
Bizarre nuclear atypia Present 6 1 4
Absent 15 1 19
Atypical mitotic figure Present 5 2 7
Absent 16 0 16
Polypectomy resection margin involvement Present 5 1 (by HSIL) 6
Absent 14 1 15
Not applicable 1 0 1
Conization diagnosis Residual SCC 0 0 0
Residual HSIL 5 1 6
No residual lesion 5 0 5
Conization resection margin involvement Present 0 Not applicable 0
Absent 10 Not applicable 10
Hysterectomy diagnosis Residual SCC 0 0 0
Residual HSIL 2 1 3
No residual lesion 5 0 5
and invasion depth of invasive carcinoma were <1 mm in
both patients with SCC (International Federation of
Gynecology and Obstetrics stage IA1). In three
representative cases, detailed histopathological features of
HSIL and SCC involving ECP are as follows.
Case 10: An umbrella-shaped, pedunculated polyp
included several, round-to-ovoid, dilated endocervical glands
(Figures 2A, B) and randomly scattered glandular lumina
filled with mucin. A few centrally located glands also
stretched along the long axis of the polyp. Fibrotic stroma
contained some thick-walled blood vessels and ectatic veins.
Areas of atypical squamous epithelium were patchily
distributed along the surface of the polyp, with variable
degrees of nuclear enlargement, hyperchromasia, and
pleomorphism. Several foci showing suspected CIN 2 were
observed (Figures 2C-F), but p16 immunostaining was
patchy positive, which does not support the diagnosis of
HSIL. A few microscopic areas of definite HSIL were p16
block positive (Figures 2G-H). The homogeneous
proliferation of atypical squamous epithelial cells with severe
nuclear pleomorphism at the basal and parabasal layers
extending throughout the entire epithelial thickness were
characteristic of HSIL (Figure 2I).
Case 11: An ovoid polyp with a short stalk had a central,
ovoid, dilated glandular lumen containing clear mucinous
material (Figures 3A-B). The surface of the head was almost
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Figure 2. Histopathological features of endocervical polyp (ECP) in case 10. (A) Scan view. (B) Boxes indicate location of subsequent medium-
power views. (C to F) Several areas show atypical squamous lesions along ECP surface and morphologically low- to high-grade squamous
intraepithelial lesions, namely suspected cervical intraepithelial neoplasia (CIN) 2. Box (right lower corner) in each image shows p16 patchy
positivity, indicating low-grade squamous intraepithelial lesion. (G) Another atypical squamous lesion is located at mid-portion of stalk. (H) Medium-
power view reveals full-thickness proliferation of homogeneous squamous epithelium, consistent with high-grade squamous intraepithelial lesion
(HSIL; CIN 3). Box (right lower corner) shows p16 block positivity. (I). High- power view shows nuclear hyperchromasia and pleomorphism
occupying entire epithelial thickness.
totally consumed by HSIL, with p16 block positivity
throughout the surface (Figure 3C), and HSIL extensively
involved the endocervical glands embedded within the
stroma. Nuclear hyperchromasia, pleomorphism (Figure 3D),
frequent mitotic figures and a few atypical mitoses were
features of tumor cells (Figure 3E). A small microscopic nest
of tumor cells in a single focus in the stromal-epithelial
junction penetrated the stroma (Figure 3F). The maximum
size and invasion depth of SCC were <1 mm.
Case 12: A leaf-shaped polyp featured a few centrally
located, elongated, dilated glandular lumina and a broad base
without a stalk (Figures 4A, B). Focal inflammatory
infiltrates with granulation tissue at the tip of the polyp were
probably due to chronic irritation. The HSIL extensively
involved the endocervical glands with expansile growth
(Figures 4C-E), and some had a keratinized surface
(keratinizing HSIL). Immunostaining revealed p16 block
positivity.
The resection margin was involved in polypectomy
specimens of five patients with HSIL (23.8%) and in one
with SCC. One patient with SCC underwent radical
hysterectomy. Four HSIL patients received further treatment,
and one did not. Two of the four patients with HSIL were
treated only by total hysterectomy, and the other two were
treated by conization and subsequent total hysterectomy. All
the five hysterectomy or conization specimens except from
the one patient who was not further treated had residual
HSIL. Furthermore, conization specimens revealed residual
HSIL in two HSIL patients and in one SCC patient, whose
polypectomy resection margins were negative for HSIL or
SCC. Chronic cervicitis with reactive epithelial atypia and
squamous and tubal metaplasia, hemorrhage, and focal
fibrosis were identified in the previous conization bed of
conization specimens with no apparent residual lesions. The
conization resection margin was not involved in any of these
patients.
Discussion
Berzolla et al. (3) reported that the prevalence of dysplasia
and malignancy arising in ECP is 0.5% (12/2,246) and
0.09% (2/2,246), respectively. Similarly, Chin et al. (23)
reported that the prevalence rate of SIL involving ECP is
0.4% (7/1,900). In a larger cohort study by Long et al. (24),
the overall risk of dysplasia arising in ECP was 0.3%
(9/3,256). Here, we analyzed the prevalence of HSIL and
SCC in a cohort of Korean patients with ECP. The
prevalence of HSIL (1.1%; 21/1,905) and SCC (0.1%;
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Figure 3. Histopathological features of endocervical polyp: case 11. (A) Scan view. (B) Boxes indicate location of subsequent medium-power views.
(C) Immunostaining highlights high-grade squamous intraepithelial lesion (HSIL) with p16 block positivity. Most of polyp surface involves HSIL
but not stalk or resection margin. (D) Medium-power view shows HSIL. Mild lymphocytic infiltration is evident in subepithelial stroma. (E) High-
power view shows frequent mitotic figures (small green arrows). Small red arrow shows typical mitotic figure. Box (right lower corner) shows
tripolar mitosis. (F) Large yellow arrow indicates microscopic stromal invasion, characterized by protrusion of tumor cells from stromal-epithelial
junction into stroma. Invasive focus measures <1 mm.
2/1,905) involving ECP in our cohort was similar to the rates
found in these studies.
Although eight (38.1%) of 21 patients with HSIL were
aged <45 years, the average age of two patients with SCC
was 58 years. The younger patients tended to have HSIL
than SCC involving ECP, reflecting the fact that HSIL occurs
in younger persons and progresses to SCC. Moreover, the
number of patients with SCC in the present study was too
small to detect a significant difference.
Histological features of invasive carcinoma in two patients
with SCC comprised HSIL with protruding microscopic
tumor cell nests <1 mm that extended from the stromal-
epithelial junction to the subepithelial stroma, which was
unlikely to be visualized by the naked eye. Moreover, the
HSIL distribution on polyp surfaces was random and in
various sizes; thus, identifying uninvolved regions with the
naked eye was difficult. The gross appearance of the polyp
surface varied regardless of HSIL as a result of erosion,
inflammation, granulation tissue formation, and fibrosis from
chronic irritation.
The rate of concordance between the presence of HSIL or
SCC and high-risk HPV detection in the present study was
88.2% (16/18). Furthermore, when considering ASC-H and
worse as a standard for cytological interpretation, the
cytohistological concordance rate was 63.1% (12/19). The
reason for this was most likely sampling error due to ECP
being located within the endocervix and not being found
during routine speculum or colposcopic examination. We
also found that patients with discordant results had
noncontinuous, randomly distributed HSIL areas admixed
with squamous metaplasia and multifocal LSIL. In contrast,
most patients with concordant results had continuous HSIL
that involved most of the polyp surface and many had
exposure outside the external os due to large polyps. Taken
together, our results suggest that when HSIL or SCC
involves ECP, the diagnostic value derived from HPV tests
or cytological examinations would be limited.
Our results indicate that there are limitations in terms of
predicting concurrent HSIL or SCC from colposcopic
appearance, HPV status, or cytological results prior to
polypectomy. Therefore, a thorough pathological examination
after polypectomy is warranted so that clinicians can be
informed about resection margin involvement. Five of 23 of
our patients had HSIL involving the polypectomy resection
margin. One patient with SCC underwent radical
hysterectomy, and two patients each with HSIL underwent
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Figure 4. Histopathological features of endocervical polyp: case 12. (A) Scan view. (B) Boxes indicate location of subsequent medium-power views.
(C to E) Extensive, multifocal glandular extension of high-grade squamous intraepithelial lesion (HSIL). Box in right lower corner of image E
shows block p16 positivity.
total hysterectomy and conization. Tissues removed from all
five patients showed residual HSIL. In the absence of clear
guidelines for the method of polypectomy or changing its
regions, these results suggest that involvement of the
polypectomy resection margin is an important factor in
predicting residual HSIL even when HSIL or SCC involving
ECP is not clinically suspected. Hysterectomy will be needed
for patients with polypectomy resection margin involvement
to remove possible residual lesions, and therapeutic
conization will be necessary for those whose fertility should
be maintained. However, polypectomy resection margin
involvement cannot be concluded as an absolute predictor
marker for residual HSIL. This is because residual HSIL was
found in two patients with HSIL who did not have
polypectomy resection margin involvement and in conization
specimens from one patient with SCC. These findings suggest
that a separate HSIL can exist in nonpolypoid cervical
mucosa, and that additional treatment will be necessary
regardless of polypectomy resection margin involvement.
When HSIL was accompanied by ECP, the mean size of
the largest polyp with histological grade CIN 2 was smaller
than that of CIN 3 (5 vs. 15.2 mm). However, the
significance remains indeterminate, as only three patients
had CIN 2. Differences in the mean largest size of ECP (13.9
vs. 15.5 mm) in HSIL and SCC could not be statistically
compared, because only two patients had SCC. The rate and
extent of the unusual histological features of HSIL, such as
marked nuclear enlargement, severe nuclear pleomorphism,
and atypical mitotic figures, did not significantly differ
between patients with HSIL and SCC. This finding is in
agreement with that of a study by Stewart (25) who reported
that pleomorphic epithelial changes (marked nuclear atypia
often associated with multinucleation) in HSIL do not
necessarily indicate more aggressive biological behavior.
None of the patients, including the eight who did not
undergo further treatment, had evidence of recurrence or
metastasis during follow-up after polypectomy. Of those who
did not undergo further treatment, two patients were lost to
follow-up and four were followed up for less than 3 years.
Therefore, observation after polypectomy should not be
mistaken as a treatment option. Patients diagnosed with
HSIL and SCC involving ECP should undergo treatment
according to the management guidelines for HSIL and SCC
without ECP until more clinical data are collected to
determine the behavior. Patients in the present study were
followed up for a relatively short period. Therefore, future
studies should analyze the clinical course and outcomes of
HSIL and SCC involving ECP in a larger patient cohort over
a longer follow-up period.
In conclusion, the prevalence of HSIL (1.1%) and SCC
(0.1%) involving ECP in our cohort was similar to that is
previous studies. The presence of residual HSIL in nonpolypoid
cervical tissues in cases with polypectomy resection margin
involvement suggest that conization or hysterectomy is needed
for diagnostic or treatment purposes. Since cervicovaginal
cytology or HPV tests have insufficient diagnostic value as a
screening tool for HSIL and SCC involving ECP, a thorough
pathological examination of polypectomy specimens is
required to provide sufficient clinicopathological information
to clinicians for appropriate management.
Conflicts of Interest
The Authors declare that they have no conflicts of interest.
Authors’ Contributions
All Authors made substantial contributions to the conception and
design of the study; the acquisition, analysis, and interpretation of
the data; drafting of the article; critical revision of the article for
important intellectual content; and the final approval of the version
to be published.
Acknowledgements
This research was supported by the Chungnam National University
Hospital Research Fund (2019), by the National Research
Foundation of Korea (NRF) grant funded by the Korea government
(Ministry of Science and ICT) (2019R1G1A1100578), and by a
Grant of Translational R&D Project through Institute for Bio-
Medical Convergence (Incheon St. Mary’s Hospital, College of
Medicine, The Catholic University of Korea).
References
1 Farrar HK, Jr. and Nedoss BR: Benign tumors of the uterine
cervix. Am J Obstet Gynecol 81: 124-137, 1961. PMID:
13698265. DOI: 10.1016/s0002-9378(16)36314-1
2 Schnatz PF, Ricci S and O’Sullivan DM: Cervical polyps in
postmenopausal women: is there a difference in risk?
Menopause 16: 524-528, 2009. PMID: 19179926. DOI: 10.1097/
gme.0b013e3181927286 
3 Berzolla CE, Schnatz PF, O’Sullivan DM, Bansal R, Mandavilli
S and Sorosky JI: Dysplasia and malignancy in endocervical
polyps. J Womens Health 16: 1317-1321, 2007. PMID:
18001188. DOI: 10.1089/jwh.2007.0408
4 Golan A, Ber A, Wolman I and David MP: Cervical polyp:
evaluation of current treatment. Gynecol Obstet Invest 37: 56-
58, 1994. PMID: 8125411. 
5 Kurman RJ, Carcangiu ML, Herrington CS and Young RH:
WHO Classification of Tumours of Female Reproductive
Organs. IARC: Lyon, France, 2014.
6 Darragh TM, Colgan TJ, Thomas Cox J, Heller DS, Henry MR,
Luff RD, McCalmont T, Nayar R, Palefsky JM, Stoler MH,
Wilkinson EJ, Zaino RJ, Wilbur DC and Members of the LPWG:
The Lower Anogenital Squamous Terminology Standardization
project for HPV-associated lesions: background and consensus
recommendations from the College of American Pathologists
and the American Society for Colposcopy and Cervical
Pathology. Int J Gynecol Pathol 32: 76-115, 2013. PMID:
23202792. DOI: 10.1097/PGP.0b013e31826916c7
in vivo 34: 2613-2621 (2020)
2620
7 Bae GE, Do SI, Kim K, Park JH, Cho S and Kim HS: Increased
sphingosine kinase 1 expression predicts distant metastasis and
poor outcome in patients with colorectal cancer. Anticancer Res
39: 663-670, 2019. PMID: 30711943. DOI: 10.21873/anticanres.
13161
8 Bae GE, Yoon N, Cho EY, Kim HS and Cho SY:
Clinicopathological and molecular characteristics of mammary
adenoid cystic carcinoma with adipocytic differentiation with
emphasis on the identification of a novel BRAF mutation.
Anticancer Res 39: 369-374, 2019. PMID: 30591482. DOI:
10.21873/anticanres.13121
9 Chung T, Do SI, Na K, Kim G, Jeong YI, Kim YW and Kim HS:
Stromal p16 overexpression in gastric-type mucinous carcinoma
of the uterine cervix. Anticancer Res 38: 3551-3558, 2018.
PMID: 29848709. DOI: 10.21873/anticanres.12627
10 Joo JW, Kim HS, Do SI and Sung JY: Expression of zinc finger
and BTB domain-containing 7A in colorectal carcinoma.
Anticancer Res 38: 2787-2792, 2018. PMID: 29715100. DOI:
10.21873/anticanres.12522
11 Jung YY, Sung JY, Kim JY and Kim HS: Down-regulation of B-
cell translocation gene 1 by promoter methylation in colorectal
carcinoma. Anticancer Res 38: 691-697, 2018. PMID: 29374692.
DOI: 10.21873/anticanres.12274
12 Park CK and Kim HS: Clinicopathological characteristics of
ovarian metastasis from colorectal and pancreatobiliary
carcinomas mimicking primary ovarian mucinous tumor.
Anticancer Res 38: 5465-5473, 2018. PMID: 30194204. DOI:
10.21873/anticanres.12879
13 Sung JY, Jung YY and Kim HS: Clinicopathological
characteristics and KRAS mutation status of endometrial
mucinous metaplasia and carcinoma. Anticancer Res 38: 2779-
2786, 2018. PMID: 29715099. DOI: 10.21873/anticanres.12521
14 Na K and Kim HS: Clinicopathologic and molecular
characteristics of mesonephric adenocarcinoma arising from the
uterine body. Am J Surg Pathol 43: 12-25, 2019. PMID:
29189288. DOI: 10.1097/PAS.0000000000000991
15 Jang MI, Sung JY, Kim JY and Kim HS: Clinicopathological
characteristics of metaplastic papillary tumor of the fallopian
tube. Anticancer Res 37: 3693-3701, 2017. PMID: 28668862. 
16 Na K and Kim HS: Clinicopathological characteristics of
fallopian tube metastases from primary endometrial, cervical,
and nongynecological malignancies: A single institutional
experience. Virchows Arch 471: 363-373, 2017. PMID:
28702779. DOI: 10.1007/s00428-017-2186-z
17 Na K, Lee JY, Sung JY, Kim GM, Koo JS and Kim HS:
Comparative clinicopathological and cytomorphological analyses
of peritoneal carcinomatosis associated with metastatic breast
carcinoma and primary peritoneal/ovarian carcinoma in patients
with a history of breast carcinoma. Virchows Arch 473: 165-175,
2018. PMID: 29926183. DOI: 10.1007/s00428-018-2390-5
18 Na K, Sung JY and Kim HS: Stromal p16 overexpression in
adult granulosa cell tumors of the ovary. Anticancer Res 37:
2437-2444, 2017. PMID: 28476811. DOI: 10.21873/anticanres.
11583
19 Na K, Sung JY and Kim HS: TP53 mutation status of tubo-
ovarian and peritoneal high-grade serous carcinoma with a wild-
type p53 immunostaining pattern. Anticancer Res 37: 6697-
6703, 2017. PMID: 29187446. DOI: 10.21873/anticanres.12128
20 Bae GE, Yoon G, Song YJ and Kim HS: High-grade squamous
intraepithelial lesion arising adjacent to vulvar lymphangioma
circumscriptum: a tertiary institutional experience. Oncotarget
7: 48120-48129, 2016. PMID: 27329721. DOI: 10.18632/
oncotarget.10158
21 Jung YY, Nahm JH and Kim HS: Cytomorphological
characteristics of glassy cell carcinoma of the uterine cervix:
histopathological correlation and human papillomavirus
genotyping. Oncotarget 7: 74152-74161, 2016. PMID:
27708230. DOI: 10.18632/oncotarget.12361
22 Yoon N, Kim JY and Kim HS: Clinical outcomes of advanced-
stage glassy cell carcinoma of the uterine cervix: a need for
reappraisal. Oncotarget 7: 78448-78454, 2016. PMID:
27793022. DOI: 10.18632/oncotarget.12905
23 Chin N, Platt AB and Nuovo GJ: Squamous intraepithelial
lesions arising in benign endocervical polyps: a report of 9 cases
with correlation to the Pap smears, HPV analysis, and
immunoprofile. Int J Gynecol Pathol 27: 582-590, 2008. PMID:
18753960. DOI: 10.1097/PGP.0b013e31817e0928
24 Long ME, Dwarica DS, Kastner TM, Gallenberg MM,
Chantigian PD, Marnach ML, Weaver AL and Casey PM:
Comparison of dysplastic and benign endocervical polyps. J
Low Genit Tract Dis 17: 142-146, 2013. PMID: 22885648. DOI:
10.1097/LGT.0b013e318260e32f
25 Stewart CJR: High-grade squamous intraepithelial lesion (HSIL)
of the cervix with bizarre cytological appearances (‘pleomorphic
HSIL’): a review of 19 cases. Pathology 49: 465-470, 2017.
PMID: 28666641. DOI: 10.1016/j.pathol.2017.05.002
Received June 2, 2020
Revised June 22, 2020
Accepted June 24, 2020
Park et al: Squamous Cell Tumors Involving Endocervical Polyps
2621
